| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $154.2M | +10.9% | +53.3% |
| Cost of Revenue | $28.0M | -32.2% | +31.2% |
| Gross Profit | $126.2M | +29.1% | +59.2% |
| R&D Expense | $31.9M | -88.6% | +34.2% |
| SG&A Expense | $36.9M | -85.3% | +149.9% |
| Operating Income | -$6.1M | +99.0% | -58.5% |
| Pre-tax Income | -$1.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $261.3M | +10.2% | -2.3% |
| Short-term Investments | $218.7M | +24.2% | — |
| Accounts Receivable | $86.8M | -12.6% | — |
| Inventory | $13.8M | -1.3% | — |
| Current Assets | $658.9M | +10.1% | — |
| Total Assets | $769.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $107.5M | — | — |
| Capital Expenditures | $300K | — | — |
| Investing Cash Flow | -$76.1M | — | — |
| Financing Cash Flow | -$70.9M | — | — |
| Free Cash Flow | $107.2M | — | — |
| +99.7% |
| -213.0% |
| Income Tax | $206K | +163.2% | -81.4% |
| Net Income | -$1.8M | +99.7% | -640.8% |
| EPS (Basic) | -$0.02 | +99.8% | -300.0% |
| EPS (Diluted) | -$0.02 | +99.8% | -300.0% |
| +11.0% |
| — |
| Current Liabilities | $357.1M | +13.7% | — |
| Total Liabilities | $361.9M | +13.1% | — |
| Stockholders' Equity | $208.0M | +19.7% | +145.0% |